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1.8 cm2) with a left ventricular ejection frac-
tion of about 50%. 
Surprisingly, a pseudoaneurysm in the apical 
region of the left ventricle was found. The pres-
ence of a connection with the left ventricle by 
a channel (FIGURE 1A) and a bidirectional flow was 
confirmed (FIGURE 1B). Importantly, the pseudoa-
neurysm was not observed on follow-up echo-
cardiography a few days after the procedure. Be-
cause of the low quality of TTE images, multislice 
computed tomography (MSCT) was performed, 
which confirmed the presence of pseudoaneu-
rysm—localized, contrast -filled outpouching 
(18 × 19 × 17 mm) with a narrow neck (width of 
1–2 mm) (FIGURE 1C and 1D). The patient report-
ed a reduction of symptoms (from New York 
Heart Association class III to I) and no potential 
pseudoaneurysm -related symptoms since TAVI. 
Because of the high risk of another procedure 
Transcatheter aortic valve implantation (TAVI) 
is used to treat patients with severe symptom-
atic aortic stenosis at intermediate to very high 
surgical risk or with contraindications to surgi-
cal aortic valve replacement. The transapical ac-
cess is the second most widely used approach in 
TAVI. It has been perceived as the most invasive 
access and connected with a higher risk of com-
plications as compared with the femoral access.1,2
An 84 -year -old male with severe symptomat-
ic aortic stenosis and a history of coronary ar-
tery bypass grafting 6 years earlier was sched-
uled for TAVI because of a high surgical risk. Due 
to the previous implantation of the stent graft 
to the abdominal aorta, the transapical access 
was chosen for TAVI. A 26 -mm Edwards Sapi-
en 3 transcatheter heart valve (Edwards Life-
sciences, Irvine, California, United States) was 
successfully implanted. Standard transthoracic 
echocardiography (TTE) performed 4 weeks af-
ter the implantation confirmed good function of 
the implanted valve (peak and mean transvalvu-
lar gradients of 24.5 mm Hg and 13.3 mm Hg, 
respectively, with an effective orifice area of 
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FIGURE 1 Transthoracic echocardiography of the pseudoaneurysm; A – a 2 ‑chamber apical projection showing 
the channel connecting the pseudoaneurysm with the left ventricle (arrow); B – a bidirectional flow revealed in 
the channel connecting the pseudoaneurysm with the left ventricle 
Abbreviations: LV, left ventricle
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of the pseudoaneurysm should be tailored to the 
individual patient, based on the results of all ex-
aminations and patient symptoms.
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and no progression of the pseudoaneurysm, 
the patient was considered ineligible for sur-
gery and was scheduled for a regular echocar-
diographic follow-up. He received dual antiplate-
let therapy; however, a month after TAVI, clop-
idogrel was discontinued due to the diagnosis 
of a left ventricular pseudoaneurysm. He did 
not require an oral anticoagulant. A gradual de-
crease in the size of the pseudoaneurysm was 
observed 3 and 6 months later. One year after 
TAVI, contrast TTE for better visualization and 
assessment of the pseudoaneurysm was per-
formed (FIGURE 1E).
Left ventricular apical pseudoaneurysm is 
an infrequent complication of TAVI, occurring 
in less than 1% of the procedures via the transapi-
cal route.3 In previously published cases, a TAVI-
-related pseudoaneurysm required surgical re-
pair4 or percutaneous closure.3 However, simi-
larly to our case, a conservative treatment seems 
possible in selected cases.5 A regular echocardio-
graphic follow -up after TAVI, especially in pa-
tients treated via the transapical approach, is 
necessary to recognize complications, includ-
ing a potentially fatal apical pseudoaneurysm. 
MSCT should be performed to expand the di-
agnostic workup or in case of doubt. Further-
more, an MSCT examination precisely shows 
the left ventricular wall, the size of the pseudo-
aneurysm, and the presence of additional con-
nections. A decision on the treatment method 
FIGURE 1 Imaging of the pseudoaneurysm (arrows); 
C – multislice computed tomography; D – multislice 
computed tomography after multiplanar reconstruction;  
E – contrast transthoracic echocardiography 1 year after 
transcatheter aortic valve implantation 
Abbreviations: LA, left atrium; LV, left ventricle; RA, right 
atrium; RV, right ventricle
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